Collegium Pharmaceutical (COLL) Accumulated Expenses (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Accumulated Expenses of $58.1 million for Q1 2026, up 1299.47% year-over-year from $4.2 million in Q1 2025, and down 6.91% quarter-over-quarter from $62.5 million in Q4 2025.
Collegium Pharmaceutical (COLL) Accumulated Expenses (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Accumulated Expenses history runs 13 years deep, the most recent figure standing at $58.1 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 1299.47% year-over-year to $58.1 million; the TTM figure through Mar 2026 stood at $58.1 million (up 1299.47% YoY), while the FY2025 annual figure was $62.5 million, down 13.39% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $58.1 million, down from $62.5 million in the prior quarter.
- The five-year high for Accumulated Expenses was $72.1 million in Q4 2024, with the low at $467000.0 in Q3 2022.
- The 5-year median for Accumulated Expenses is $4.3 million (2024), against an average of $21.5 million.
- Peak annual rise in Accumulated Expenses reached 4632.3% in 2022, while the deepest fall reached 97.73% in 2022.
- Collegium Pharmaceutical's Accumulated Expenses stood at $1.2 million in 2022, then surged by 136.18% to $2.9 million in 2023, then jumped by 2428.01% to $72.1 million in 2024, then decreased by 13.39% to $62.5 million in 2025, then declined by 6.91% to $58.1 million in 2026.
- Business Quant data shows COLL's Accumulated Expenses at $58.1 million in Q1 2026, $62.5 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Collegium Pharmaceutical | 892.67 Mn | 743.35 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.25 Mn |
| Mar 31, 2026 | 58.15 Mn |
| Dec 31, 2025 | 62.46 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 4.28 Mn |
| Mar 31, 2025 | 4.16 Mn |
| Dec 31, 2024 | 72.12 Mn |
| Sep 30, 2024 | 4.33 Mn |
| Jun 30, 2024 | 38.73 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 2.85 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 2.67 Mn |
| Mar 31, 2023 | 24.43 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 467,000.00 |
| Jun 30, 2022 | 39.70 Mn |
| Mar 31, 2022 | 41.07 Mn |
| Dec 31, 2021 | 29.21 Mn |
| Sep 30, 2021 | 20.59 Mn |